NuVasive SVP Sells $174,300 in Stock (NUVA)
NuVasive (NASDAQ:NUVA) SVP Craig Hunsaker unloaded 4,980 shares of the stock in a transaction dated Tuesday, January 7th. The shares were sold at an average price of $35.00, for a total transaction of $174,300.00. Following the transaction, the senior vice president now directly owns 21,142 shares of the company’s stock, valued at approximately $739,970. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.
Several analysts have recently commented on the stock. Analysts at Barclays raised their price target on shares of NuVasive from $32.00 to $35.00 in a research note to investors on Thursday. They now have an “equal weight” rating on the stock. Separately, analysts at Zacks downgraded shares of NuVasive from an “outperform” rating to a “neutral” rating in a research note to investors on Thursday, January 2nd. They now have a $35.40 price target on the stock. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and eight have issued a buy rating to the company. NuVasive has an average rating of “Hold” and a consensus price target of $29.34.
NuVasive (NASDAQ:NUVA) traded up 0.48% during mid-day trading on Thursday, hitting $35.23. 374,672 shares of the company’s stock traded hands. NuVasive has a 52 week low of $16.57 and a 52 week high of $35.38. The stock’s 50-day moving average is $32.69 and its 200-day moving average is $27.43. The company’s market cap is $1.572 billion.
NuVasive (NASDAQ:NUVA) last released its earnings data on Tuesday, October 29th. The company reported $0.39 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.24 by $0.15. The company had revenue of $169.20 million for the quarter, compared to the consensus estimate of $158.30 million. During the same quarter in the prior year, the company posted $0.23 earnings per share. The company’s quarterly revenue was up 14.0% on a year-over-year basis. Analysts expect that NuVasive will post $1.14 EPS for the current fiscal year.
NuVasive, Inc (NASDAQ:NUVA) is a medical device company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.